Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

cardinal health - ziprasidone hydrochloride (unii: 216x081oru) (ziprasidone - unii:6uka5vej6x) - ziprasidone 20 mg

Canada - engleză - Health Canada

bgp pharma ulc - eprosartan (eprosartan mesylate); hydrochlorothiazide - tablet - 600mg; 12.5mg - eprosartan (eprosartan mesylate) 600mg; hydrochlorothiazide 12.5mg - angiotensin ii receptor antagonists

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

unit dose services - ziprasidone hydrochloride (unii: 216x081oru) (ziprasidone - unii:6uka5vej6x) - ziprasidone 20 mg

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

remedyrepack inc. - ziprasidone hydrochloride (unii: 216x081oru) (ziprasidone - unii:6uka5vej6x) - ziprasidone hydrochloride 20 mg

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - ziprasidone hydrochloride (unii: 216x081oru) (ziprasidone - unii:6uka5vej6x) - ziprasidone hydrochloride 20 mg

Canada - engleză - Health Canada

otsuka pharmaceutical co ltd - busulfan - solution - 60mg - busulfan 60mg - antineoplastic agents

Canada - engleză - Health Canada

pfizer canada ulc - deferoxamine mesylate - powder for solution - 500mg - deferoxamine mesylate 500mg - heavy metal antagonists

Canada - engleză - Health Canada

pfizer canada ulc - deferoxamine mesylate - powder for solution - 2g - deferoxamine mesylate 2g - heavy metal antagonists

Canada - engleză - Health Canada

boehringer ingelheim animal health canada inc. - pergolide (pergolide mesylate) - tablet - 1mg - pergolide (pergolide mesylate) 1mg - horses

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

padagis us llc - bromocriptine mesylate (unii: ffp983j3od) (bromocriptine - unii:3a64e3g5zo) - bromocriptine 2.5 mg - bromocriptine mesylate tablets are indicated for the treatment of dysfunctions associated with hyperprolactinemia including amenorrhea with or without galactorrhea, infertility or hypogonadism . bromocriptine mesylate tablets treatment is indicated in patients with prolactin-secreting adenomas , which may be the basic underlying endocrinopathy contributing to the above clinical presentations. reduction in tumor size has been demonstrated in both male and female patients with macroadenomas. in cases where adenectomy is elected, a course of bromocriptine mesylate tablets therapy may be used to reduce the tumor mass prior to surgery. bromocriptine mesylate tablets therapy is indicated in the treatment of acromegaly. bromocriptine mesylate tablets therapy, alone or as adjunctive therapy with pituitary irradiation or surgery, reduces serum growth hormone by 50% or more in approximately ½ of patients treated, although not usually to normal levels. since the effects of external pituitary radiation may not become